")}("position","absolute",["\/lib\/bootstrap\/dist\/css\/bootstrap.min.css"],"rel=\u0022stylesheet\u0022 ");
Published On: Wednesday, September 15, 2021 | By: Team KnowMyStock
It is one of the major manufacturers of PIs like Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban of which first two contributed around 44 per cent of FY21 revenues.According to stock market experts, current valuations of the stock is not conducive for fresh buying but they advised Ami Organics shareholders to further hold the counter maintaining trailing stop loss at ₹945.
Follow Us On: